Progress on a new MS therapy — shaped by the people it's for.
At IMMUTOL's 3rd Annual Meeting in Siena 🇮🇹, EMSP brought expert patients Rebecca Maguire & Anna Revilla into the room as the consortium advanced its vitamin D3 dendritic cell therapy for MS. 🧠
516 patients per nurse.
That's the average caseload uncovered by our survey of 108 MS nurses across 15 countries.
Clinical trials, psychological support and benefits advice routinely left undone
Systemic change is overdue #InternationalNursesDay
Learm more bit.ly/4fghEwG
EMSP highlights its EU-funded projects this #WorldMSDay:
🔹 #WISDOM: secure data + AI for MS insights
🔹 #MoreEUROPA: better use of registry data for patient-centred care
🔹 #BEHINDMS: EBV’s role in MS via immune interactions
🔹 #EBVMS: why EBV leads to MS & antiviral approaches
📍 RiMS 2026 | 11–13 June | Prague
The leading European gathering on MS rehabilitation — from neuroplasticity to real-world outcomes that matter most for people with MS.
"Coping with MS" panel, chaired by EMSP CEO
Elisabeth Kasilingam
🔗 rehabinms.org/meetings-det... #RiMS2026
Our Community Coordinator Anna Revilla Bruñol was in Seville for PEOF 2026, bringing the voices of young people with MS, NMOSD & MOGAD into discussions on patient engagement.
Read her takeaways: bit.ly/3S4Ktme
18–35? Join the YPN 👉 bit.ly/4utxYy8
Welcome to the team, Delphine Sartiaux — our new Fundraising & Development Manager!
Delphine brings rich experience in fundraising, strategic partnerships & international stakeholder engagement across global health NGOs.
Delighted to have her on board 👋
1.2M people live with MS in Europe and access to treatment still depends on where you live.
This May, our members DMSG & MS Ireland
are taking on #TheMay50K, led by MSIF.
Every kilometre moves research and equity forward.
Register- bit.ly/4tYB8ul